FORM OF STOCK OPTION AGREEMENT GOVERNED BY THE TERMS, CONDITIONS AND LIMITATIONS OF THE ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLANStock Option Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledDecember 18th, 2015 Company IndustryThis Stock Option Agreement (this “Option Agreement”) certifies that the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted an option (the “Option”) to purchase shares of the Company’s common stock, $.001 par value per share (the “Shares”), that is governed by the terms, conditions and limitations of the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), as follows:
Executive Employment AgreementExecutive Employment Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 18th, 2015 Company Industry JurisdictionARIAD Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Paris Panayiotopoulos (the “Employee”), an individual, enter into this Executive Employment Agreement as of December 16, 2015 (the “Agreement”).
FORM OF RESTRICTED STOCK UNIT AGREEMENT GOVERNED BY THE TERMS, CONDITIONS AND LIMITATIONS OF THE ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLANRestricted Stock Unit Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledDecember 18th, 2015 Company IndustryThis Restricted Stock Unit Agreement (this “Restricted Stock Unit Agreement”) certifies that the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted an unvested right to receive shares of Common Stock, $.001 par value per share, of the Company (the “RSUs”), payable as soon as administratively feasible following each of the following vesting dates, assuming the Participant is then employed by the Company, that is governed by the terms, conditions and limitations of the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), as follows: